- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01575093
Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The preparation regimen used for the PillCam® Colon 2 procedure consists of several colon cleansing materials.
Different combinations of the above regimen were tested and evaluated for safety by monitoring of adverse events in multiple clinical studies, with more than 1000 subjects enrolled to date. No Serious Adverse Events related to the preparation were noted.
In this study, each subject will be required to undergo serum chemistry tests (blood tests) at several time points to evaluate the safety of the regimen.
No capsule ingestion is involved.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 2
- Fas 1
Kontakter och platser
Studieorter
-
-
Alabama
-
Anniston, Alabama, Förenta staterna, 36207
- Pinnacle Research Group, LLC
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Subject is between 50 - 75 years of age.
- Subject is healthy without any known disease, or any current symptoms of any disease or other abnormal condition.
- Subject received an explanation about the nature of the study and agrees to provide written informed consent.
- Subject has normal serum chemistry tests at baseline.
Exclusion Criteria:
- Subject has any allergy or other known contraindication to the medications used in the study.
- Subject with history or clinical evidence of renal disease and/or previous clinically significant laboratory abnormalities of renal function parameters.
- Subject has Type 1 or Type II Diabetes.
- Subject has any condition which precludes compliance with study instructions.
- Women who are either pregnant or nursing at the time of screening, or are of child-bearing potential and do not practice medically acceptable methods of contraception.
- Subject suffers from life threatening conditions.
- Concurrent participation in another clinical trial using any investigational drug or device.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
To evaluate the safety of a bowel preparation regimen comprised of Sulfate free Polyethylene glycol electrolyte lavage solution (SF-PEG) plus SUPREP oral sulfate solution as a "booster", in adult subjects.
Tidsram: Latest blood test conducted (i.e. 24 hours after suppository or seven days after procedure)
|
Safety will be evaluated by number of Adverse Events and percentage of subjects with clinically siginifcant change in serum chemistry test.
|
Latest blood test conducted (i.e. 24 hours after suppository or seven days after procedure)
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: PANKAJ K. KASHYAP, M.D., Pinnacle Research Group, LLC
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- MA-112
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .